News

New drug combination could improve adherence to tuberculosis treatment

Published on 23 October 2014 in 'News, Announcements'

A novel combination of the drugs rifapentine and moxifloxacin can reduce the number of tablets to be taken by patients from 360 to 140 over the six-month tuberculosis treatment period.

Read more »

Mefloquine not recommended as alternative drug for malaria prevention treatment in pregnancy

Published on 24 September 2014 in 'News, Announcements'

The results of two large randomised controlled trials conducted in Africa that tested mefloquine, a drug for malaria prevention in HIV-negative and HIV-positive pregnant women, were published in the PLOS Medicine on 23 September 2014. The results sho...

Read more »

Proceedings of the EDCTP stakeholder meeting on capacity development published

Published on 23 September 2014 in 'News, Announcements'

The European & Developing Countries Clinical Trials Partnership (EDCTP) published its report of the Stakeholder meeting on capacity development. The meeting was held in Berlin, Germany, on 3 July 2014 and hosted by the German Federal Ministry of Scie...

Read more »

Current state of health research on poverty-related diseases in sub-Saharan Africa

Published on 19 September 2014 in 'News, Announcements'

Today, the European & Developing Countries Clinical Trials Partnership (EDCTP), RAND Europe and Baird’s CMC have published a report on the current state of health research and national funding commitments for HIV/AIDS, tuberculosis, malaria and negle...

Read more »

Launch of the second EDCTP programme against poverty-related diseases in Africa

Published on 8 September 2014 in 'News, Announcements'

A high-level event in Cape Town, South Africa, on 2 December 2014 will celebrate the launch of the second programme of the European & Developing Countries Clinical Trials Partnership (EDCTP2).

Read more »

REMoxTB trial results confirm moxifloxacin safety but not shortened tuberculosis treatment

Published on 8 September 2014 in 'News, Announcements'

The results of REMoxTB, a phase III global clinical trial of new tuberculosis drug regimens, were published in the New England Journal of Medicine. The trial was led by Prof. Stephen H. Gillespie (St. Andrews University, Scotland) and conducted mainl...

Read more »

TAM-TB: New sputum-independent diagnostic tool for tuberculosis in children

Published on 1 September 2014 in 'Announcements, News'

The diagnosis of paediatric tuberculosis is marred with difficulty, mainly due to the challenge in collecting sputum samples. A European & Developing Countries Clinical Trials-funded project (TB CHILD) has developed a new immunodiagnostic tool TAM-...

Read more »

Displaying results 1 to 7 out of 247
<< First < Previous 1 2 3 4 5 6 7 8 9 10 Next > Last >>